Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Contrei is 0.3% (very low). The 2024 annual accounts show negative equity (€-15k) and a net result of €-30k. Its solvency ranks better than 5% of 6575 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.3%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+Annual accounts: weaker financial profile
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Signals
1 signal · with evidenceNegative equity
Equity is negative for financial year 2024: liabilities exceed assets. This is the trigger point of the alarm-bell procedure (Belgian CAC).
View the annual accounts Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Filing behaviour
From the deposit records, complete market-wideDeadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 14 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 11-07-2025, 20 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
How we compute the deadline
The year end is derived from 2 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | nothing on record | not filed | - |
| 31-12-2024 | 31-07-2025 | 11-07-2025 | 20 d early | 2025-00264932 |
| 31-12-2023 | 31-07-2024 | 13-08-2024 | 13 d late | 2024-00343128 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsMore than 3 years active
Founded in 2022, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-30k-23.0%
Working capital€275k-10.0%
Annual accounts & ratios
Source: NBB · 2024Annual accounts filed on 11-07-2025 with the NBB · fiscal year 2024 · micro
Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -3.6% | 66.7% | |
| Net result | €-30k | €46k | |
| Equity | €-15k | €79k | |
| Gross operating margin | €-12k | €78k | |
| Total assets | €415k | €154k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
€-30k
-23.0%
23-24
€415k
+1.2%
23-24
€-15k
-
23-24
€275k
-10.0%
23-24
€431k
+8.9%
23-24
€141k
+33.5%
23-24
€290k
0.0%
23-24
2.95
-24.2%
23-24
0.00
-95.6%
23-24
-3.6%
-
23-24
-28.41
-
23-24
200.7%
-
23-24
-7.3%
-21.5%
23-24
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | - |
| Net profit | €-30k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €415k |
| Equity | €-15k |
| Debt | €431k |
| of which ≤ 1y | €141k |
| of which > 1y | €290k |
| Working capital | €275k |
| Employees (FTE) | - |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 2.95 |
| Quick ratio | 0.00 |
| Working capital ratio | 66.2% |
| Solvency | -3.6% |
| Debt / equity | -28.41 |
| Long-term debt ratio | -19.13 |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -7.3% |
| ROE | 200.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €415k |
| Current assets | 29/58 | €415k |
| Stocks & contracts in progress | 3 | €415k |
| Amounts receivable within one year | 40/41 | €137 |
| Cash & bank | 54/58 | €0 |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €415k |
| Equity | 10/15 | €-15k |
| Contributions / capital | 10/11 | €40k |
| Accumulated profits (losses) | 14 | €-55k |
| Amounts payable | 17/49 | €431k |
| Amounts payable after one year | 17 | €290k |
| Amounts payable within one year | 42/48 | €141k |
| Trade debts payable within one year | 44 | €11k |
| Income statement | ||
| Gross operating margin | 9900 | €-12k |
| Operating result | 9901 | €-14k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €17k |
| Result before taxes | 9903 | €-30k |
| Net result for the period | 9904 | €-30k |
| Result to be appropriated | 9905 | €-30k |
You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2024 · computed37
/ 100
Weak
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Directors
Directors & mandates
2 directorsCurrent directors & mandates
-
Current17-02-2026 → present
Former directors (1)
-
Former- → 17-02-2026
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Insolvency mandates
No insolvency mandates (liquidators, administrators) on record for this company.
Legal Structure
| NACE primary | Activiteiten van verpleegkundigen en verloskundigen(86940) |
| Legal form | Private limited company(610) |
| Incorporation | 01-04-2022 |
| Status | Active |
| Postal code | 3945 |
Structure & network
Locations & real estate
Registered office
from the Crossroads BankCannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Broekstraat 103945 HamEstablishment units
1 locationContrei
since 20222.331.086.677
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area540 m²
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71033A0249/00L000 | Flanders | 540 m² | - | - |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
2 acts All acts · 2
updated 5 months ago
2026
17-02-2026 Articles of association amended
Summary:
v3.2
2022
05-04-2022 Incorporation of a new BV
Summary:
oprichting
Analysis
Snowflake analysis
financial profile on 5 axes66
/ 100
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Health
37
Profitability
100
Solvency
67
Growth
32
Stability
94
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soonAI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Credit advice
verdict per customer and amountSimilar
Similar companies
Comparable size, same sectorBE 0805.246.686 · Ieper
BE 0784.827.493 · Gembloux
BE 0769.547.718 · Beerse
BE 0792.412.497 · Liège
BE 0780.633.531 · Ardooie
We hold annual accounts for 731 of the 5,945 companies in this sector. 648 of them are within a factor 10 of this company's equity.
Company registry
Company registry (CBE)
Crossroads BankActivities
Activiteiten van verpleegkundigen en verloskundigen86940Overige bouwinstallatie43240Overige bouwinstallatie, n.e.g.43299Bemiddeling in verband met exploitatie van en handel in onroerend goed68310Overige zakelijke dienstverlening, n.e.g.82990Overige zakelijke dienstverlening, neg82990
Primary activity highlighted.
Names & trade names
| Legal nameNL | Contrei |
Registered office
Broekstraat 10 bus b
3945 Ham, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.